Clinical Trial Update: Atenolol Versus Losartan in the Prevention of Progressive Dilation of the Aorta in Marfan Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing atenolol and losartan to prevent progressive dilation of the aorta in Marfan syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marfan Syndrome

Drugs mentioned

• Atenolol (Atenolol)
• Losartan (losartan)

Snippet

Sponsor: Forteza, Albert, M.D. | Conditions: Marfan Syndrome | Phase 3 | Status: UNKNOWN